47 分钟on MSN
Biogen outlines $15.25-$16.25 EPS guidance for 2026 while advancing growth products and ...
Q4 2025 Management View Christopher Viehbacher, President, CEO & Director, opened by stating, "We finished the year strongly ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果